Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ZAMAGNI, Elena")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 22 of 22

  • Page / 1
Export

Selection :

  • and

The role of imaging techniques in the management of multiple myelomaZAMAGNI, Elena; CAVO, Michele.British journal of haematology. 2012, Vol 159, Num 5, pp 499-513, issn 0007-1048, 15 p.Article

Maintenance therapy in newly diagnosed multiple myeloma: current recommendationsBRIOLI, Annamaria; TACCHETTI, Paola; ZAMAGNI, Elena et al.Expert review of anticancer therapy. 2014, Vol 14, Num 5, pp 581-594, issn 1473-7140, 14 p.Article

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma : randomised controlled trial. CommentaryKUMAR, Shaji; PALUMBO, Antonio; GALLI, Monica et al.Lancet (British edition). 2006, Vol 367, Num 9513, issn 0140-6736, 791-792,825-831 [9 p.]Article

Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantationZAMAGNI, Elena; PATRIARCA, Francesca; PANTANI, Lucia et al.Blood. 2011, Vol 118, Num 23, pp 5989-5995, issn 0006-4971, 7 p.Article

Combination of International Scoring System 3, High Lactate Dehydrogenase, and t(4; 14) and/or del(17p) Identifies Patients With Multiple Myeloma (MM) Treated With Front-Line Autologous Stem-Cell Transplantation at High Risk of Early MM Progression-Related DeathMOREAU, Philippe; CAVO, Michele; VAN DER HOLT, Bronno et al.Journal of clinical oncology. 2014, Vol 32, Num 20, pp 2173-2180, issn 0732-183X, 8 p.Article

Short-Term Thalidomide Incorporated Into Double Autologous Stem-Cell Transplantation Improves Outcomes in Comparison With Double Autotransplantation for Multiple MyelomaCAVO, Michele; DI RAIMONDO, Francesco; CALIFANO, Catello et al.Journal of clinical oncology. 2009, Vol 27, Num 30, pp 5001-5007, issn 0732-183X, 7 p.Article

First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myelomaCAVO, Michele; ZAMAGNI, Elena; TURA, Sante et al.Haematologica (Roma). 2004, Vol 89, Num 7, pp 826-831, issn 0390-6078, 6 p.Article

Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantationSOVERINI, Simona; CAVO, Michele; GRAFONE, Tiziana et al.Blood. 2003, Vol 102, Num 5, pp 1588-1594, issn 0006-4971, 7 p.Article

Bortezomib-Based Versus Nonbortezomib-Based Induction Treatment Before Autologous Stem-Cell Transplantation in Patients With Previously Untreated Multiple Myeloma: A Meta-Analysis of Phase III Randomized, Controlled TrialsSONNEVELD, Pieter; GOLDSCHMIDT, Hartmut; DESAI, Avinash et al.Journal of clinical oncology. 2013, Vol 31, Num 26, pp 3279-3287, issn 0732-183X, 9 p.Article

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized TrialPALUMBO, Antonio; CAVO, Michele; NOZZOLI, Chiara et al.Journal of clinical oncology. 2011, Vol 29, Num 8, pp 986-993, issn 0732-183X, 8 p.Article

Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantationTOSI, Patrizia; RONCONI, Sonia; ZAMAGNI, Elena et al.Haematologica (Roma). 2001, Vol 86, Num 4, pp 409-413, issn 0390-6078Article

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 studyCAVO, Michele; TACCHETTI, Paola; OFFIDANI, Massimo et al.Lancet (British edition). 2010, Vol 376, Num 9758, pp 2075-2085, issn 0140-6736, 11 p.Article

Systemic Cardiac Amyloidoses: Disease Profiles and Clinical Courses of the 3 Main TypesRAPEZZI, Claudio; MERLINI, Giampaolo; COCCOLO, Fabio et al.Circulation (New York, N.Y.). 2009, Vol 120, Num 13, pp 1203-1212, issn 0009-7322, 10 p.Article

Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma : Bologna 96 clinical studyCAVO, Michele; TOSI, Patrizia; NARNI, Franco et al.Journal of clinical oncology. 2007, Vol 25, Num 17, pp 2434-2441, issn 0732-183X, 8 p.Article

Superiority of thalidomide and dexamethasone over vincristine-doxorubicin-dexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma. CommentaryCAVO, Michele; ZAMAGNI, Elena; GRAFONE, Tiziana et al.Blood. 2005, Vol 106, Num 1, issn 0006-4971, 2, 35-39 [6 p.]Article

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myelomaCAVO, Michele; PANTANI, Lucia; NOZZOLI, Chiara et al.Blood. 2012, Vol 120, Num 1, pp 9-19, issn 0006-4971, 11 p.Article

Multiple Myeloma, Venous Thromboembolism, and Treatment-Related Risk of ThrombosisZAMAGNI, Elena; BRIOLI, Annamaria; TACCHETTI, Paola et al.Seminars in thrombosis and hemostasis. 2011, Vol 37, Num 3, pp 209-219, issn 0094-6176, 11 p.Article

A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myelomaZAMAGNI, Elena; NANNI, Cristina; CECCOLINI, Michela et al.Haematologica (Roma). 2007, Vol 92, Num 1, pp 50-55, issn 0390-6078, 6 p.Article

Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical studyCAVO, Michele; BENNI, Monica; RONCONI, Sonia et al.Haematologica (Roma). 2002, Vol 87, Num 9, pp 934-942, issn 0390-6078Article

Novel mutation and RNA splice variant of fibroblast growth factor receptor 3 in multiple myeloma patients at diagnosisSOVERINI, Simona; TERRAGNA, Carolina; TURA, Sante et al.Haematologica (Roma). 2002, Vol 87, Num 10, pp 1036-1040, issn 0390-6078Article

Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myelomaTOSI, Patrizia; ZAMAGNI, Elena; MASINI, Luciano et al.Haematologica (Roma). 2002, Vol 87, Num 4, pp 408-414, issn 0390-6078Article

Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantationMARTINELLI, Giovanni; TERRAGNA, Carolina; BUONAMICI, Silvia et al.Haematologica (Roma). 2000, Vol 85, Num 9, pp 930-934, issn 0390-6078Article

  • Page / 1